CIPLA USA

Pharmaceutical ManufacturingFlorida, United States51-200 Employees

CIPLA USA is a pharmaceutical manufacturing company based in Miami, Florida, focused on producing medicines for the U.S. market. The business maintains operations across manufacturing, quality control, engineering, and general operations, reflecting its production-centric role in the sector. It is a mid-sized producer in the pharmaceutical manufacturing sector, with facilities and functions that cover core production disciplines.

The company's product history includes the launch of Leuprolide Acetate Injection Depot 22.5 mg in 2022 and Daptomycin for Injection in 2019, illustrating its involvement in injectable therapies for the U.S. market. It has faced quality and regulatory events, such as a 2021 recall of six batches of Albuterol Sulfate inhalation Aerosol (90 mcg), disclosed in later reporting. More recently, CIPLA USA has been recognized as a Great Place To Work in 2023 and again in 2025, and it is actively recruiting for roles across manufacturing, quality control, engineering, and operations.

Sign up for free to view info

Email Format Employee directory